Form 4: Castle Biosciences Executive Tobin Juvenal Reports Stock Transactions

Tobin W. Juvenal, Chief Commercial Officer of Castle Biosciences, reports acquisition and disposal of company stock and restricted stock units on March 4, 2025.

Summary

• On March 4, 2025, Tobin W. Juvenal, the Chief Commercial Officer of Castle Biosciences, engaged in transactions involving the company's common stock and restricted stock units (RSUs).
• Juvenal acquired 13,811 shares of common stock through the vesting of RSUs.
• He also disposed of 5,573 shares to cover tax obligations at a price of $22.23 per share.
• Following these transactions, Juvenal directly owns 78,181 shares of common stock and indirectly owns 2,230 shares through a family trust.
• He also directly owns 47,838 RSUs, which vest in four equal annual installments beginning on March 4, 2026, and 41,432 RSUs from a previous grant.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by an executive. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Future Outlook

The reporting person holds RSUs that will vest in the future, indicating continued alignment with the company's performance.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's stock.

Comparison to Industry Standards

• Executive compensation packages often include RSUs to align management's interests with those of shareholders.
• The vesting schedule of the RSUs (four equal annual installments) is a common practice.
• The disposal of shares to cover tax obligations upon vesting is also a standard procedure.

Stakeholder Impact

• Shareholders may be interested in the transactions of company insiders as an indicator of management's confidence in the company.
• The disposal of shares to cover tax obligations is a normal part of executive compensation and should not be interpreted as a negative signal.

Key Dates

Keywords

Form 4, Insider Trading, Restricted Stock Units, Common Stock, Castle Biosciences, CSTL, Tobin Juvenal, Executive Compensation